BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22066647)

  • 1. Sublingual vaccination with fusion protein consisting of the functional domain of hemagglutinin A of Porphyromonas gingivalis and Escherichia coli maltose-binding protein elicits protective immunity in the oral cavity.
    Yuzawa S; Kurita-Ochiai T; Hashizume T; Kobayashi R; Abiko Y; Yamamoto M
    FEMS Immunol Med Microbiol; 2012 Mar; 64(2):265-72. PubMed ID: 22066647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasal immunization with a fusion protein consisting of the hemagglutinin A antigenic region and the maltose-binding protein elicits CD11c(+) CD8(+) dendritic cells for induced long-term protective immunity.
    Du Y; Hashizume T; Kurita-Ochiai T; Yuzawa S; Abiko Y; Yamamoto M
    Infect Immun; 2011 Feb; 79(2):895-904. PubMed ID: 21115722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sublingual vaccination with outer membrane protein of Porphyromonas gingivalis and Flt3 ligand elicits protective immunity in the oral cavity.
    Zhang T; Hashizume T; Kurita-Ochiai T; Yamamoto M
    Biochem Biophys Res Commun; 2009 Dec; 390(3):937-41. PubMed ID: 19852927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host responses to recombinant hemagglutinin B of Porphyromonas gingivalis in an experimental rat model.
    Katz J; Black KP; Michalek SM
    Infect Immun; 1999 Sep; 67(9):4352-9. PubMed ID: 10456874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcutaneous immunization with a 40-kDa outer membrane protein of Porphyromonas gingivalis induces specific antibodies which inhibit coaggregation by P. gingivalis.
    Maeba S; Otake S; Namikoshi J; Shibata Y; Hayakawa M; Abiko Y; Yamamoto M
    Vaccine; 2005 Mar; 23(19):2513-21. PubMed ID: 15752838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of immune responses and prevention of alveolar bone loss by intranasal administration of mice with Porphyromonas gingivalis fimbriae and recombinant cholera toxin B subunit.
    Takahashi Y; Kumada H; Hamada N; Haishima Y; Ozono S; Isaka M; Yasuda Y; Tochikubo K; Umemoto T
    Oral Microbiol Immunol; 2007 Dec; 22(6):374-80. PubMed ID: 17949339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasal vaccination with the 40-kilodalton outer membrane protein of Porphyromonas gingivalis and a nontoxic chimeric enterotoxin adjuvant induces long-term protective immunity with reduced levels of immunoglobulin E antibodies.
    Momoi F; Hashizume T; Kurita-Ochiai T; Yuki Y; Kiyono H; Yamamoto M
    Infect Immun; 2008 Jun; 76(6):2777-84. PubMed ID: 18411288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal immunization with a flagellin-adjuvanted Hgp44 vaccine enhances protective immune responses in a murine Porphyromonas gingivalis infection model.
    Puth S; Hong SH; Park MJ; Lee HH; Lee YS; Jeong K; Kang IC; Koh JT; Moon B; Park SC; Rhee JH; Lee SE
    Hum Vaccin Immunother; 2017 Dec; 13(12):2794-2803. PubMed ID: 28604268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcutaneous immunization with an outer membrane protein of Porphyromonas gingivalis without adjuvant elicits marked antibody responses.
    Koizumi Y; Kurita-Ochiai T; Yamamoto M
    Oral Microbiol Immunol; 2008 Apr; 23(2):131-8. PubMed ID: 18279181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on the induction of the humoral immune responses to Bacteroides gingivalis fimbrial antigen in mice].
    Shimauchi H
    Osaka Daigaku Shigaku Zasshi; 1990 Jun; 35(1):60-77. PubMed ID: 1983739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of monophosphoryl lipid A augmentation of host responses to recombinant HagB from Porphyromonas gingivalis.
    Yang QB; Martin M; Michalek SM; Katz J
    Infect Immun; 2002 Jul; 70(7):3557-65. PubMed ID: 12065496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral immunization with Porphyromonas gingivalis outer membrane protein and CpGoligodeoxynucleotides elicits T helper 1 and 2 cytokines for enhanced protective immunity.
    Liu C; Hashizume T; Kurita-Ochiai T; Fujihashi K; Yamamoto M
    Mol Oral Microbiol; 2010 Jun; 25(3):178-89. PubMed ID: 20502628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of preexisting immunity to Salmonella on the immune response to recombinant Salmonella enterica serovar typhimurium expressing a Porphyromonas gingivalis hemagglutinin.
    Kohler JJ; Pathangey LB; Gillespie SR; Brown TA
    Infect Immun; 2000 Jun; 68(6):3116-20. PubMed ID: 10816452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasal immunization with the 40-kDa outer membrane protein of Porphyromonas gingivalis plus cholera toxin induces protective immunity in aged mice.
    Cai Y; Kurita-Ochiai T; Kobayashi R; Hashizume T; Yamamoto M
    J Oral Sci; 2013; 55(2):107-14. PubMed ID: 23748449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral immunization with recombinant Salmonella typhimurium expressing a cloned Porphyromonas gingivalis hemagglutinin: effect of boosting on mucosal, systemic and immunoglobulin G subclass response.
    Kohler JJ; Pathangey LB; Brown TA
    Oral Microbiol Immunol; 1998 Apr; 13(2):81-8. PubMed ID: 9573798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination with recombinant adhesins from the RgpA-Kgp proteinase-adhesin complex protects against Porphyromonas gingivalis infection.
    Frazer LT; O'Brien-Simpson NM; Slakeski N; Walsh KA; Veith PD; Chen CG; Barr IG; Reynolds EC
    Vaccine; 2006 Oct; 24(42-43):6542-54. PubMed ID: 16839648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody responses to Porphyromonas gingivalis hemagglutinin A and outer membrane protein in chronic periodontitis.
    Kobayashi T; Kaneko S; Tahara T; Hayakawa M; Abiko Y; Yoshie H
    J Periodontol; 2006 Mar; 77(3):364-9. PubMed ID: 16512750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of a cholera toxin B subunit Porphyromonas gingivalis fimbrial antigen fusion protein expressed in E. coli.
    Kim TG; Huy NX; Kim MY; Jeong DK; Jang YS; Yang MS; Langridge WH; Lee JY
    Mol Biotechnol; 2009 Feb; 41(2):157-64. PubMed ID: 18807220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunization with targeted fusion anticaries DNA vaccine via intramuscular route:experiment with murine].
    Yu F; Fan MW; Xu QA; Jia R; Guo JH; Bian Z; Chen Z; Peng B; Fan B
    Zhonghua Yi Xue Za Zhi; 2004 May; 84(9):754-9. PubMed ID: 15200917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination with recombinant RgpA peptide protects against Porphyromonas gingivalis-induced bone loss.
    Wilensky A; Potempa J; Houri-Haddad Y; Shapira L
    J Periodontal Res; 2017 Apr; 52(2):285-291. PubMed ID: 27282938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.